Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierantonio Menna

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|May 1, 2007
Doxorubicin degradation in cardiomyocytesPierantonio Menna, Emanuela Salvatorelli, Giorgio Minotti
Future Cardiology|August 5, 2015
Managing anthracycline-induced cardiotoxicity: beginning with the end in mindEmanuela Salvatorelli, Pierantonio Menna, Giorgio Minotti
Acta Haematologica|October 20, 2020
The Reality of Pixantrone in Real LifePierantonio Menna, Emanuela Salvatorelli, Giorgio Minotti
Chemical Research in Toxicology|April 2, 2008
Cardiotoxicity of antitumor drugsPierantonio Menna, Emanuela Salvatorelli, Giorgio Minotti
Current Cardiology Reports|March 20, 2019
Cardiotoxicity of Targeted Cancer Drugs: Concerns, "The Cart Before the Horse," and Lessons from TrastuzumabPierantonio Menna, Giorgio Minotti, Emanuela Salvatorelli
The Journal of Pharmacology and Experimental Therapeutics|March 26, 2010
Pharmacological foundations of cardio-oncologyGiorgio Minotti, Emanuela Salvatorelli, Pierantonio Menna
Cardiovascular Toxicology|July 27, 2007
An introduction to the metabolic determinants of anthracycline cardiotoxicityPierantonio Menna, Stefania Recalcati, Gaetano Cairo, et al.
Topics in Current Chemistry|April 23, 2013
Anthracycline cardiotoxicityPierantonio Menna, Emanuela Salvatorelli, Luca Gianni, et al.
British Journal of Pharmacology|February 4, 2025
Advances in Bruton tyrosine kinase (Btk) inhibition are steered by Bruton tyrosine kinase phylogenyGiorgio Minotti, Massimiliano Camilli, Emanuela Salvatorelli, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 2006
Defective taxane stimulation of epirubicinol formation in the human heart: insight into the cardiac tolerability of epirubicin-taxane chemotherapiesEmanuela Salvatorelli, Pierantonio Menna, Luca Gianni, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
The Journal of Pharmacology and Experimental Therapeutics|May 1, 2007
Doxorubicin degradation in cardiomyocytesPierantonio Menna, Emanuela Salvatorelli, Giorgio Minotti
Future Cardiology|August 5, 2015
Managing anthracycline-induced cardiotoxicity: beginning with the end in mindEmanuela Salvatorelli, Pierantonio Menna, Giorgio Minotti
Acta Haematologica|October 20, 2020
The Reality of Pixantrone in Real LifePierantonio Menna, Emanuela Salvatorelli, Giorgio Minotti
Chemical Research in Toxicology|April 2, 2008
Cardiotoxicity of antitumor drugsPierantonio Menna, Emanuela Salvatorelli, Giorgio Minotti
Current Cardiology Reports|March 20, 2019
Cardiotoxicity of Targeted Cancer Drugs: Concerns, "The Cart Before the Horse," and Lessons from TrastuzumabPierantonio Menna, Giorgio Minotti, Emanuela Salvatorelli
The Journal of Pharmacology and Experimental Therapeutics|March 26, 2010
Pharmacological foundations of cardio-oncologyGiorgio Minotti, Emanuela Salvatorelli, Pierantonio Menna
Cardiovascular Toxicology|July 27, 2007
An introduction to the metabolic determinants of anthracycline cardiotoxicityPierantonio Menna, Stefania Recalcati, Gaetano Cairo, et al.
Topics in Current Chemistry|April 23, 2013
Anthracycline cardiotoxicityPierantonio Menna, Emanuela Salvatorelli, Luca Gianni, et al.
British Journal of Pharmacology|February 4, 2025
Advances in Bruton tyrosine kinase (Btk) inhibition are steered by Bruton tyrosine kinase phylogenyGiorgio Minotti, Massimiliano Camilli, Emanuela Salvatorelli, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 2006
Defective taxane stimulation of epirubicinol formation in the human heart: insight into the cardiac tolerability of epirubicin-taxane chemotherapiesEmanuela Salvatorelli, Pierantonio Menna, Luca Gianni, et al.
Pageof 7